Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR01:59

CRISPR

52.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.6K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

105
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
105

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Humanized biparatopic nanobody-based CAR-T cells overcome antigen-heterogeneity in multiple myeloma.

Journal of translational medicine·2026
Same author

Insights from adaptive immune regulation for disease resistance breeding in livestock and poultry.

Science China. Life sciences·2026
Same author

Development of Hexaploid Wheat Germplasm with Resistance to Both Powdery Mildew and Stripe Rust by Introgression of <i>Pm60</i> and <i>YrU1</i> from <i>Triticum urartu</i>.

Plants (Basel, Switzerland)·2026
Same author

Explainable AI in Electrocatalysis and Photocatalysis: From Catalyst Design to Mechanistic Insights.

ACS applied materials & interfaces·2026
Same author

Development of a green and validated UHPLC-MS/MS method for assessing the pharmacokinetics and safety of PA-PEG<sub>12</sub>-PA in MCF-7 cells.

Analytical methods : advancing methods and applications·2026
Same author

Bioanalysis of Ametryn by UHPLC-MS<sup>3</sup> Coupled With Multiple Fragmentation to Decrease Interference and Enhance Sensitivity.

Rapid communications in mass spectrometry : RCM·2026
Same journal

Smartphone-assisted fluorescence and colorimetric dual-mode sensor for visual quantitative detection of nitrite and nitrate in real samples.

Analytica chimica acta·2026
Same journal

Folding integrated all-paper photoelectrochemical immunoassay using annealed ZnO for point-of-care detection of ferritin.

Analytica chimica acta·2026
Same journal

Dual-mode electrochemical-SERS detection of chloramphenicol based on dual-signal enhancement.

Analytica chimica acta·2026
Same journal

Multi-screening of beta-lactam antibiotics in milk based on Fe<sub>3</sub>O<sub>4</sub>@phage/bacteria system and aggregation induced emission luminogen.

Analytica chimica acta·2026
Same journal

A porous phosphate-rich β-cyclodextrin polymer for efficient and broad-spectrum enrichment of antibiotics.

Analytica chimica acta·2026
Same journal

Corrigendum to "LUMIN: A novel algorithm for automated mixture quantification using 1D <sup>1</sup>H NMR spectra" [Analytica Chimica Acta 1411 (2026) 345639].

Analytica chimica acta·2026
See all related articles

Related Experiment Video

Updated: Aug 10, 2025

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

7.9K

A universal and sensitive gene mutation detection method based on CRISPR-Cas12a.

Huajing Wang1, Ruijie Liu2, Kejun Dong3

  • 1Department of Breast Surgery, Second Hospital of Jilin University, No.218 Ziqiang Street, Nanguan District, Changchun, 130041, China; Institute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Analytica Chimica Acta
|February 10, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces a novel CRISPR/Cas12a method for highly sensitive and specific detection of single nucleotide mutations, crucial for early cancer diagnosis and treatment. The method achieves 100% accuracy in clinical samples.

Keywords:
CRISPR-Cas12aGene mutationSensitivitySpecific PCRUniversality

More Related Videos

Using a Fluorescent PCR-capillary Gel Electrophoresis Technique to Genotype CRISPR/Cas9-mediated Knockout Mutants in a High-throughput Format
08:25

Using a Fluorescent PCR-capillary Gel Electrophoresis Technique to Genotype CRISPR/Cas9-mediated Knockout Mutants in a High-throughput Format

Published on: April 8, 2017

14.0K
Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
09:03

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a

Published on: December 23, 2022

2.7K

Related Experiment Videos

Last Updated: Aug 10, 2025

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

7.9K
Using a Fluorescent PCR-capillary Gel Electrophoresis Technique to Genotype CRISPR/Cas9-mediated Knockout Mutants in a High-throughput Format
08:25

Using a Fluorescent PCR-capillary Gel Electrophoresis Technique to Genotype CRISPR/Cas9-mediated Knockout Mutants in a High-throughput Format

Published on: April 8, 2017

14.0K
Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
09:03

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a

Published on: December 23, 2022

2.7K

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • Single nucleotide mutations are key drivers in cancer development.
  • Accurate detection of these mutations is vital for clinical oncology.
  • Existing CRISPR/Cas12a detection methods have limitations in specificity and universality.

Purpose of the Study:

  • To develop a simple, rapid, and highly sensitive method for single nucleotide mutation detection using CRISPR/Cas12a.
  • To overcome the PAM sequence restriction and enhance the specificity and sensitivity of CRISPR/Cas12a.
  • To validate the clinical applicability of the developed method for cancer mutation detection.

Main Methods:

  • Development of a novel CRISPR/Cas12a-based detection system.
  • Integration with specific PCR to overcome PAM sequence limitations.
  • Detection of clinically significant mutations (PTEN R130Q, BRAF V600E, TP53 R248W).

Main Results:

  • Achieved a detection limit of 0.1% for single nucleotide mutations.
  • Demonstrated significantly improved specificity and sensitivity compared to existing methods.
  • Validated with 100% accuracy on 10 clinical samples for TP53 R248W mutation.

Conclusions:

  • The developed specific PCR combined with CRISPR/Cas12a method is simple, rapid, universal, and highly sensitive.
  • This method shows significant promise for clinical cancer diagnosis.
  • Overcoming PAM sequence restrictions enhances the clinical utility of CRISPR/Cas12a for mutation detection.